Fri, 06 Jun 2014 | DIVISION SALE
Jordans and Ryvita food brands owner, Associated British Foods (ABF), is set to purchase Dorset Cereals in a deal thought to be worth £50 million.
ABF, which also owns the Primark retail chain, was in the running for the upmarket cereal brand against rivals Kellogg’s and Weetabix.
A spokesperson for ABF said: “We can confirm that The Jordans & Ryvita Company, part of Associated British Foods, has reached an agreement to purchase the Dorset Cereals brand form Wellness Foods, subject to regulatory approval.
“Until the acquisition has been cleared by the regulatory authorities, Dorset Cereals will continue to operate as a part of Wellness Foods, and it is inappropriate for us to comment further at this stage.”
Dorset Cereal's owner Wellness Foods, is based in Surrey and is a subsidiary of Erbrium Capital Partners. Pending clearance by regulators, the £40 million turnover business will remain with Wellness Foods.
Established 26 years ago by entrepreneur Terry Crabb, he sold the cereal-making firm on to Wellness in 2008. The Dorset Cereal factory in Poundbury, Dorset will be retained if the sale is approved.
While the mainstream cereal market in Britain has been slowing down, Dorset Cereals has managed to tap in to the growing demand for healthy breakfasts, based on oats and muesli for instance. ABF’s Jordans, which features a granola cereal is also benefiting from this shift.
______________________________________________________________________
Related information:
Search for businesses for sale
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.